Combining phage display and screening of cDNA expression libraries: a new approach for identifying the target antigen

S Barth1, U Weidenmüller, M K Tur

  • 1Department of Veterinary Science, Institute of Immunology and Molecular Biology, Luisenstr. 56, University of Berlin, 10117, Germany. stefan.barth@uni-koeln.de

Insights

Identifying tumor antigens is challenging. This study shows that scFv phages can detect target antigens within a lambda phage cDNA expression library, aiding in cancer research.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Immunology

Background:

  • Phage display is used to select single-chain variable fragment (scFv) antibodies against tumor cells.
  • Identifying the specific antigen targeted by these scFv antibodies remains a significant challenge.
  • Existing methods like ELISA and FACS evaluate binding but do not definitively identify the antigen.

Purpose of the Study:

  • To demonstrate a method for detecting the target antigen of a preselected scFv displayed on phage.
  • To validate antigen detection within a complex, immobilized lambda phage cDNA expression library.

Main Methods:

  • Utilized scFv phage display libraries selected on tumor cells.
  • Employed an immobilized lambda phage cDNA expression library containing both tumor-specific and irrelevant clones (including CD30-negative breast cancer cDNA and human CD30 receptor cDNA).
  • Documented the interaction between anti-CD30 scFv phages and immobilized antigens via blotting on nitrocellulose filters.

Main Results:

  • Successfully detected the CD30 antigen using anti-CD30 scFv phages in the lambda phage cDNA expression library.
  • Demonstrated antigen detection is feasible with at least 5x10^12 plaque-forming units of filamentous phage per blot.
  • Showed successful detection across different ratios of CD30 receptor to breast cancer specific clones (1:1 and 1:200).

Conclusions:

  • Phage-displayed scFv can identify their target antigens within complex cDNA expression libraries.
  • This technique provides a novel approach to antigen discovery in cancer research.
  • Facilitates the characterization of tumor-associated antigens and the development of targeted therapies.

Related Concept Videos